ArticleJournal of gastrointestinal cancer2026
Clusters of Anthropometric Features in Colorectal Cancer Patients with Synchronous Metastases and Their Association with Overall Survival and RAS Mutation.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03873064 (Body Mass Index), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnthropometric traits—such as height, body mass index (BMI), and age—are shaped by genetic, nutritional, and environmental factors, which may also be influential in colorectal cancer (CRC). We investigated whether sex-adjusted variations in these parameters could be associated with different subtypes of CRC and overall survival outcomes.
methodsWe analyzed patients with synchronous metastatic CRC enrolled in the prospective BMI-QoL study (NCT03873064). Age, height, and BMI were standardized and subjected to k-means clustering (k = 2, 25 random initializations). Principal component analysis was used to visualize cluster separation in two dimensions. “Core cluster members” were defined using sex-specific cutoffs for all three variables, excluding borderline cases. Difference in Overall survival (OS) between clusters was assessed using Kaplan–Meier and Cox proportional hazards models; clinical and molecular features were compared using chi-square and Mann–Whitney tests.
resultsTwo reproducible clusters emerged. Cluster 1 comprised younger, taller, normal-to-overweight patients; Cluster 2 included older, shorter, underweight patients. Core cluster 1 members (n = 23) had significantly longer OS than core cluster 2 members (n = 31) (median OS 51.1 vs. 22.0 months; HR 2.28, p = 0.03), with survival curves diverging beyond 24 months. Non-core members had intermediate OS (median 31 months). Age, height, and BMI individually were not significant OS predictors. RAS wild-type tumors were more prevalent in core cluster 1 (61%) than core cluster 2 (32%, p = 0.03). CEA levels and metastatic patterns did not differ between clusters.
conclusionSex-adjusted anthropometric profiling identifies two prognostically distinct mCRC subtypes. The association of better survival with higher BMI, younger age and taller stature—alongside increased prevalence of RAS wild-type tumors—supports the biological relevance of these profiles. Larger prospective validation integrating anthropometric and genomic data is warranted.
Indexed as
Identifiers
41870755What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.